Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 4/20 | 0.43 |
| ▸ | PDE4A | P27815 | 1/20 | 0.37 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.37 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 2/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.35 |
| ▸ | HTR1A | P08908 | 2/20 | 0.34 |
| ▸ | HTR7 | P34969 | 2/20 | 0.34 |
| ▸ | HTR6 | P50406 | 2/20 | 0.34 |
| ▸ | TTR | P02766 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20754152 | 0.87 | AHR (0.39) | AHRCA1CA2CNR2MAOA | |
| SCHEMBL21109290 | 0.84 | AHR (0.44) | AHRPDE4APDE4CPDE4DCA1 | |
| SCHEMBL24601973 | 0.80 | AHR (0.41) | AHRCNR2MAOAHTR6TTR | |
| SCHEMBL30751952 | 0.79 | MAOA (0.40) | CNR2MAOA | |
| SCHEMBL3544562 | 0.78 | AR (0.41) | CA1CA2TTR | |
| SCHEMBL20754181 | 0.78 | AHR (0.39) | AHRCA1CA2CNR2MAOA | |
| SCHEMBL24390464 | 0.76 | AHR (0.44) | AHRCA1CA2MAOAMCL1 | |
| SCHEMBL18226861 | 0.75 | PDE4A (0.39) | PDE4APDE4CPDE4DCNR2MAOA | |
| SCHEMBL32691372 | 0.75 | DAO (0.33) | AHRPDE4APDE4CPDE4DMAOA | |
| SCHEMBL21331558 | 0.74 | AHR (0.44) | AHRCNR2MAOAHTR6TTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11844271-B2 | Organic compound, composition, organic optoelectronic device, and display apparatus | SAMSUNG SDI CO., LTD. (KR) | 2023-12-12 | — | — | US | disclosed |
| US-11844271-B2 | Organic compound, composition, organic optoelectronic device, and display apparatus | SAMSUNG SDI CO., LTD. (KR) | 2023-12-12 | — | — | US | disclosed |
| US-20230371371-A1 | ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | SAMSUNG SDI CO LTD (KR) | 2023-11-16 | — | — | US | disclosed |
| US-20230371371-A1 | ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | SAMSUNG SDI CO LTD (KR) | 2023-11-16 | — | — | US | disclosed |
| US-20200388765-A1 | ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY APPARATUS | SAMSUNG SDI CO., LTD. (KR) | 2020-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230371371-A1 | ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | OCIAD1, OXER1, OR10J3 | AHR 2046/4885PDE4A 3793/4885PDE4C 3345/4885 |
| US-20200388765-A1 | ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY APPARATUS | OCIAD1, OXER1, OR10J3 | AHR 2625/4885PDE4A 3996/4885PDE4C 3582/4885 |
| US-11844271-B2 | Organic compound, composition, organic optoelectronic device, and display apparatus | OCIAD1, OXER1, OR10J3 | AHR 2625/4885PDE4A 3996/4885PDE4C 3582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.